Skip to main content

Advertisement

Table 1 Demographic data of all 168 patients included in the study

From: Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

  THR TKR Total
Treated, n (%) 81 (100.0) 87 (100.0) 168 (100.0)
Gender, n (%)    
Male 40 (49.4) 32 (36.8) 72 (42.9)
Female 41 (50.6) 55 (63.2) 96 (57.1)
Age (years), median (Q1, Q3) 60.0 (52.0, 66.0) 64.0 (57.0, 69.0) 62.0 (55.0, 68.0)
Age class, n (%)    
<65 years 55 (67.9) 47 (54.0) 102 (60.7)
65-75 years 26 (32.1) 39 (44.8) 65 (38.7)
>75 years 0 1 (1.1) 1 (0.6)
Body mass index (kg/m2), median (Q1, Q3) 27.2 (24.3, 29.8) 29.8 (26.8, 34.3) 28.4 (25.7, 32.5)
Body mass index class, n (%)    
<25 kg/m2 25 (30.9) 11 (12.6) 36 (21.4)
25 – <30 kg/m2 37 (45.7) 33 (37.9) 70 (41.7)
30–35 kg/m2 11 (13.6) 26 (29.9) 37 (22.0)
>35 kg/m2 8 (9.9) 17 (19.5) 25 (14.9)
  1. Q Quartile, THR Total hip replacement, TKR Total knee replacement